Literature DB >> 16311341

Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.

X Tan1, H Egami, M Abe, F Nozawa, M Hirota, M Ogawa.   

Abstract

AIMS: To clarify the involvement of matrix metalloproteinase-7 (MMP-7) in cell dissociation and the subsequent invasion of pancreatic cancer cells.
METHODS: Western blotting, in vitro invasion assay, immunocytochemistry, and immunohistochemistry were performed in pancreatic cancer cell lines or pancreatic cancer tissue.
RESULTS: The active form of the MMP-7 protein was expressed exclusively in the conditioned medium of dissociated (PC-1.0 and AsPC-1) pancreatic cancer cells, whereas proMMP-7 protein was only detected in the conditioned medium of non-dissociated (PC-1 and Capan-2) cells. Both intracellular and conditioned medium localised MMP-7 was greatly reduced by treatment with the epidermal growth factor receptor (EGFR) inhibitor AG1478 and the mitogen activated protein kinase kinase (MEK) inhibitor U0126 in pancreatic cancer cells. MMP-7 treatment significantly induced the disruption of tight junction (TJ) structures and subsequent cell dissociation, and activation of the EGFR mediated MEK- ERK (extracellular signal regulated protein kinase) signalling pathway in the non-dissociated pancreatic cancer cells. Moreover, the strong in vitro invasiveness of dissociated cells was inhibited by AG1478 and U0126 treatment, whereas the weak invasiveness of non-dissociated cells was apparently induced by MMP-7 treatment. In addition, MMP-7 expression was stronger at the invasive front than at the centre of human pancreatic tumours.
CONCLUSION: MMP-7 is involved in cell dissociation and the subsequent invasion of pancreatic cancer cells. It induces the disruption of TJ structures and forms a positive feedback loop with activation of the EGFR mediated MEK-ERK signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311341      PMCID: PMC1770786          DOI: 10.1136/jcp.2004.025338

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

Review 1.  Matrix metalloproteinases in tumor invasion and metastasis.

Authors:  I Stamenkovic
Journal:  Semin Cancer Biol       Date:  2000-12       Impact factor: 15.707

2.  Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells.

Authors:  Xiaodong Tan; Hiroshi Egami; Shinji Ishikawa; Takashi Kurizaki; Masahiko Hirota; Michio Ogawa
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.

Authors:  T Torimura; T Ueno; M Kin; R Harada; T Nakamura; T Kawaguchi; M Harada; R Kumashiro; H Watanabe; R Avraham; M Sata
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

4.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells.

Authors:  X F Zhu; Z C Liu; B F Xie; Z M Li; G K Feng; D Yang; Y X Zeng
Journal:  Cancer Lett       Date:  2001-08-10       Impact factor: 8.679

6.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

Authors:  H Yamamoto; F Itoh; S Iku; Y Adachi; H Fukushima; S Sasaki; M Mukaiya; K Hirata; K Imai
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

7.  Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer.

Authors:  Xiaodong Tan; Hiroshi Egami; Hidenobu Kamohara; Shinji Ishikawa; Takashi Kurizaki; Naoya Yoshida; Yasuhiko Tamori; Eiji Takai; Masahiko Hirota; Michio Ogawa
Journal:  Int J Oncol       Date:  2004-01       Impact factor: 5.650

8.  Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasiveness.

Authors:  Nikolaus Seiler; Yann Schneider; Francine Gossé; René Schleiffer; Francis Raul
Journal:  Int J Oncol       Date:  2004-10       Impact factor: 5.650

9.  Relationship between the expression of extracellular signal-regulated kinase 1/2 and the dissociation of pancreatic cancer cells: Involvement of ERK1/2 in the dissociation status of cancer cells.

Authors:  Xiaodong Tan; Hiroshi Egami; Shinji Ishikawa; Takashi Kurizaki; Yasuhiro Tamori; Eiji Takai; Masahiko Hirota; Michio Ogawa
Journal:  Int J Oncol       Date:  2004-04       Impact factor: 5.650

10.  Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.

Authors:  Xiaodong Tan; Yasuhiro Tamori; Hiroshi Egami; Shinji Ishikawa; Takashi Kurizaki; Eiji Takai; Masahiko Hirota; Michio Ogawa
Journal:  Oncol Rep       Date:  2004-05       Impact factor: 3.906

View more
  22 in total

1.  Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.

Authors:  Zhi-Chao Jia; Yuan-Lian Wan; Jian-Qiang Tang; Yun Dai; Yu-Cun Liu; Xin Wang; Jing Zhu
Journal:  Int J Colorectal Dis       Date:  2011-11-12       Impact factor: 2.571

2.  Mechanotransduction of extracellular signal-regulated kinases 1 and 2 mitogen-activated protein kinase activity in smooth muscle is dependent on the extracellular matrix and regulated by matrix metalloproteinases.

Authors:  Karen J Aitken; Gregory Block; Armando Lorenzo; Daniel Herz; Nesrin Sabha; Omar Dessouki; France Fung; Marta Szybowska; Laura Craig; Darius J Bägli
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine?

Authors:  Richard R Keld; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 4.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability.

Authors:  P Loma; A Guzman-Aranguez; M J Pérez de Lara; J Pintor
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 6.  Molecular biology of pancreatic cancer.

Authors:  Cristóbal Belda-Iniesta; Immaculada Ibáñez de Cáceres; Jorge Barriuso; Javier de Castro Carpeño; Manuel González Barón; Jaime Feliú
Journal:  Clin Transl Oncol       Date:  2008-09       Impact factor: 3.405

7.  Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells.

Authors:  Hui Liu; Tiantuo Zhang; Benquan Wu; Jing Huang; Yuqi Zhou; Jiaxin Zhu
Journal:  Mol Biol Rep       Date:  2008-12-24       Impact factor: 2.316

8.  Targeted therapies for pancreatic cancer.

Authors:  Philip A Philip
Journal:  Gastrointest Cancer Res       Date:  2008-07

9.  Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Authors:  Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Magdalena Zietarska; Véronique Ouellet; Patricia N Tonin; Mario Chevrette; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

10.  A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors.

Authors:  Dana Inbar-Rozensal; Asher Castiel; Leonid Visochek; David Castel; Françoise Dantzer; Shai Izraeli; Malka Cohen-Armon
Journal:  Breast Cancer Res       Date:  2009-11-09       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.